Apellis Pharmaceuticals I... (APLS)
NASDAQ: APLS
· Real-Time Price · USD
20.63
0.55 (2.74%)
At close: May 02, 2025, 1:57 PM
13F Institute Ownership
Total Institutes of 283 in Apellis Pharmaceuticals reduced their positions with a decrease of 9 investors compared to the previous quarter. An additional 9.64M shares, as total invested capital grew by $668.07M with ownership percentage increasing from 94.49% to 102.27%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.320
0.32
Call Flow 2,621,100
76%
Put Flow 839,500
24%
Top Shareholders
Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
---|---|---|---|---|---|
Avoro Capital Advisors LLC | 9.86% | 12.22M | +10.00% | 390.01M | 5.52% |
Ecor1 Capital, LLC | 9.60% | 11.89M | +0.00% | 379.44M | 14.35% |
Wellington Management Group Ll... | 9.52% | 11.8M | -24.19% | 376.57M | 0.07% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.